Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03145467Phase 4Completed
Phase 4, randomised, single-blind trial in migraine comparing Paracetamol with Zolmitriptan (2 arms). Primary endpoints: Decrement of the pain on Visual Analog Scale and Decrement of the pain on Numeric Rating Scale. Started Jan 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03145467.